Lin Tu

927 total citations
38 papers, 646 citations indexed

About

Lin Tu is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lin Tu has authored 38 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Gastroenterology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Lin Tu's work include Gastrointestinal Tumor Research and Treatment (19 papers), Gastric Cancer Management and Outcomes (9 papers) and Gastrointestinal disorders and treatments (7 papers). Lin Tu is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (19 papers), Gastric Cancer Management and Outcomes (9 papers) and Gastrointestinal disorders and treatments (7 papers). Lin Tu collaborates with scholars based in China, Germany and Taiwan. Lin Tu's co-authors include Wenyi Zhao, Zhigang Zhang, Yong Luo, Nanqu Huang, Juan Huang, Chun Zhuang, Zizhen Zhang, Hui Cao, Hang Li and Hui Cao and has published in prestigious journals such as Cancer Research, Scientific Reports and Cancer Letters.

In The Last Decade

Lin Tu

37 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Tu China 17 297 197 176 152 111 38 646
Gabriella Gaudioso Italy 16 369 1.2× 156 0.8× 228 1.3× 86 0.6× 221 2.0× 29 778
Nam-Gyun Kim South Korea 9 428 1.4× 151 0.8× 305 1.7× 144 0.9× 157 1.4× 11 854
Maria Chiara Anania Italy 12 258 0.9× 175 0.9× 108 0.6× 120 0.8× 142 1.3× 15 558
Ferdous M. Barlaskar United States 8 258 0.9× 106 0.5× 260 1.5× 27 0.2× 122 1.1× 10 697
Wenyi Zhao China 18 445 1.5× 231 1.2× 337 1.9× 130 0.9× 236 2.1× 43 879
Weiming Yue China 17 394 1.3× 154 0.8× 180 1.0× 26 0.2× 192 1.7× 49 812
Silvia Gisfredi Italy 14 241 0.8× 169 0.9× 117 0.7× 25 0.2× 219 2.0× 25 598
Jiryeon Jang South Korea 21 447 1.5× 323 1.6× 271 1.5× 43 0.3× 425 3.8× 30 1.0k
Takeshi Niinuma Japan 17 617 2.1× 132 0.7× 388 2.2× 68 0.4× 120 1.1× 39 872
Yangzi Tian China 13 310 1.0× 361 1.8× 187 1.1× 116 0.8× 182 1.6× 28 785

Countries citing papers authored by Lin Tu

Since Specialization
Citations

This map shows the geographic impact of Lin Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Tu more than expected).

Fields of papers citing papers by Lin Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Tu. The network helps show where Lin Tu may publish in the future.

Co-authorship network of co-authors of Lin Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Tu. A scholar is included among the top collaborators of Lin Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Tu. Lin Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lu, Xiaojing, Yuzhi Pang, Hui Cao, et al.. (2021). Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors. Cancer Research. 81(9). 2481–2494. 31 indexed citations
3.
Zhuang, Chun, Bo Ni, Zizhen Zhang, et al.. (2021). Low Distribution of TIM-3+ Cytotoxic Tumor-Infiltrating Lymphocytes Predicts Poor Outcomes in Gastrointestinal Stromal Tumors. Journal of Immunology Research. 2021. 1–10. 4 indexed citations
4.
Li, Yuanyuan, Nanqu Huang, Fei Feng, et al.. (2020). Icaritin Improves Memory and Learning Ability by Decreasing BACE‐1 Expression and the Bax/Bcl‐2 Ratio in Senescence‐Accelerated Mouse Prone 8 (SAMP8) Mice. Evidence-based Complementary and Alternative Medicine. 2020(1). 8963845–8963845. 14 indexed citations
6.
Yang, Linxi, Ming Wang, Lin Tu, et al.. (2019). [Application of imatinib plasma concentration monitoring in the whole process management of gastrointestinal stromal tumor patients].. PubMed. 22(9). 841–847. 1 indexed citations
7.
Huang, Juan, et al.. (2019). Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development. Frontiers in Oncology. 9. 506–506. 100 indexed citations
8.
Tu, Lin, Peter Hohenberger, Heike Allgayer, & Hui Cao. (2018). Standard Approach to Gastrointestinal Stromal Tumors - Differences between China and Europe. Visceral Medicine. 34(5). 353–358. 9 indexed citations
9.
Shi, Jinfeng, et al.. (2017). Phenotypic classification of gastric signet ring cell carcinoma and its relationship with K-ras mutation. Genetics and Molecular Research. 16(2). 4 indexed citations
10.
Li, Rongkun, Chun Zhuang, Shu‐Heng Jiang, et al.. (2017). ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer. Journal of Cancer. 8(18). 3764–3773. 24 indexed citations
11.
Tu, Lin, Ming Wang, Wenyi Zhao, et al.. (2016). miRNA-218-loaded carboxymethyl chitosan - Tocopherol nanoparticle to suppress the proliferation of gastrointestinal stromal tumor growth. Materials Science and Engineering C. 72. 177–184. 20 indexed citations
12.
Tian, Guang-Ang, Chunchao Zhu, Xiao-Xin Zhang, et al.. (2016). CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib. Scientific Reports. 6(1). 31071–31071. 25 indexed citations
13.
Zhang, Zizhen, Gang Zhao, Chun Zhuang, et al.. (2016). Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes. Scientific Reports. 6(1). 27435–27435. 20 indexed citations
14.
Tu, Lin, Jia Xu, Ming Wang, et al.. (2016). Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer. Tumor Biology. 37(7). 8775–8782. 11 indexed citations
15.
Tu, Lin, et al.. (2016). Investigating the role of polymorphisms in miR-146a, -149, and -196a2 in the development of gastric cancer. Genetics and Molecular Research. 15(2). 13 indexed citations
16.
Wang, Ming, Jia Xu, Yun Zhang, et al.. (2014). Gastrointestinal stromal tumor: 15-years’ experience in a single center. BMC Surgery. 14(1). 93–93. 22 indexed citations
18.
Li, Rongkun, Wenyi Zhao, Fang Fang, et al.. (2014). Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway. Journal of Cancer Research and Clinical Oncology. 141(2). 269–281. 56 indexed citations
19.
Zhao, Wenyi, Jia Xu, Ming Wang, et al.. (2014). Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome. BMC Gastroenterology. 14(1). 105–105. 8 indexed citations
20.
Wang, Jingxing, Yi Huang, Julin Li, et al.. (2011). Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion. 51(12). 2588–2595. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026